InvestorsHub Logo
Followers 4
Posts 382
Boards Moderated 0
Alias Born 05/10/2021

Re: vcf5502 post# 12880

Monday, 10/17/2022 2:34:37 PM

Monday, October 17, 2022 2:34:37 PM

Post# of 20567
Yes. Truly. It is sad when your hopes and dreams are for a nickel.

I think you’re mostly joking. As obviously there would have to be a catalyst first. I don’t expect to wake up tomorrow to the news of an RS with out any approvals, or a significant order being PAID for, not just placed. That would be a disaster in my opinion. And they know that. Which is why they haven’t done it.

Maybe they would make a huge bet if there was a big Monkey Pox or Covid outbreak. But that would be so risky. Not worth it when things appear to very slowly and unsteadily coming together and aligning for this company. It looks like cash will last long enough for MP, cancer, and Alzheimer’s testing to get approved. I didn’t list Tollovid because I only give it 50/50 odds. All three of those stars align and revenue will go up $10 million year one, then $10 a quarter as they get in a rhythm year 2. Then $10 million a month year 3. That will get us a SP of $5 the old fashion way. But I suspect they would absolutely get bought Q3 of year two for the equivalent of maybe $3 a share based on current SP.